InVivo Therapeutics’ CEO Frank Reynolds to Appear on KTVK-TV’s Good Morning Arizona
CAMBRIDGE, Mass. (November 7, 2011) – InVivo Therapeutics Holdings Corp. (OTC/BB: NVIV), a developer of groundbreaking technologies for the treatment of spinal cord injuries (SCI), today announced that CEO Frank Reynolds will appear on KTVK-TV’s Good Morning Arizona on Thursday, November 10th at 8:15am MST.
With the some 12,000 new cases of traumatic spinal cord injury each year, InVivo Therapeutics has pioneered a new treatment system that uses a biocompatible polymer-based scaffold to provide structural support to a damaged spinal cord in order to promote healing and improve patients recovery and prognosis after a traumatic spinal cord injury. Reynolds will discuss the scaffold and how it works in the spinal cords of monkeys.
“We expect that our technology will change the standard of care for spinal cord injury treatment. We’re currently under review at the FDA and we look forward to receiving approval from the FDA to begin human studies,” said Reynolds. “Our therapeutic approach confirms a clear paradigm in the treatment of spinal cord injuries, and we look forward to being on Good Morning Arizona.”
KTVK-TV’s Good Morning Arizona is the #1 morning show in Phoenix and airs weekdays from 5am-9am MST.